Journal article
The Safety of Long-Acting β-Agonists among Patients with Asthma Using Inhaled Corticosteroids
Abstract
RATIONALE: Inhaled long-acting beta-agonists (LABAs), when used as monotherapy in asthma, may increase asthma-related hospitalizations, life threatening events requiring intubation/mechanical ventilation, and asthma-related deaths, but concomitant use of inhaled corticosteroids (ICS) may modify this effect.
OBJECTIVES: To determine the safety of long-acting beta-agonists among patients with asthma using corticosteroids.
Authors
Jaeschke R; O'Byrne PM; Mejza F; Nair P; Lesniak W; Brozek J; Thabane L; Cheng J; Schünemann HJ; Sears MR
Journal
American Journal of Respiratory and Critical Care Medicine, Vol. 178, No. 10, pp. 1009–1016
Publisher
American Thoracic Society
Publication Date
November 15, 2008
DOI
10.1164/rccm.200804-494oc
ISSN
1073-449X